American Express Co. stock outperforms competitors
Is It Too Late to Buy American Express Stock?
Shares of American Express (NYSE: AXP) have skyrocketed to an all-time high with a 44% return this year, outperforming the 20% gain in the S&P 500 index. The financial services giant has benefited from resilient macroeconomic conditions, driving solid growth and stronger earnings. Shareholders have had plenty to cheer about lately.
American Express (AXP) closed the latest trading day at $271.20, indicating a +0.05% change from the previous session's end. This move lagged the S&P 500's daily gain of 0.42%. Meanwhile, the Dow ...
Analyst Donald Fandetti from Wells Fargo maintained a Buy rating on American Express (AXP – Research Report) and increased the price ...
The Delta SkyMiles American Express Card lineup recently released fresh, limited-time offers for new personal and business ...
If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider American Express ...
Analysts have been eager to weigh in on the Financial sector with new ratings on American Express (AXP – Research Report) and SEI Investments ...
Credit cards are a handy financial tool for a number of reasons, but I’ve always been interested in them for the rewards they ...
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from ...
Our opinions are our own. American Express made its name with cards that were as much status symbols as payment methods. In the 21st century, the issuer offers a complete line of cards with ...
4d
Few cards are as well-known as Centurion cards. But does the Business Centurion deserve the hype? Read our full Amex Business ...
American Express and Visa are both major credit card networks, but they’re certainly not the same. Using an American Express card, or Amex card, can imply a certain level of prestige and ...
NVIDIA, American Express, Wells Fargo, Elite Pharmaceuticals and PrimeEnergy are included in this Analyst Blog.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback